Stock Events

Stock Events

Lonza Group 

M$11,842.56
167
+M$0+0% Wednesday 15:16

Statistics

Day High
11,842.56
Day Low
11,842.56
52W High
13,580.58
52W Low
11,842.56
Volume
0
Avg. Volume
25
Mkt Cap
0
P/E Ratio
-
Dividend Yield
0.47%
Dividend
55.44

Upcoming

12
MAY
Dividend Ex
Increased
 
13
MAY
Dividend Ex
 
15
MAY
Dividend Payment
 
15
MAY
Dividend Payment
Increased
 
13
MAY 27
Dividend Ex
Estimated
 

Dividends

0.47%Dividend Yield
May 26
M$55.44
May 26
M$55.44
May 25
M$46.11
May 24
M$36.97
May 23
M$34.88
10Y Growth
N/A
5Y Growth
13.82%
3Y Growth
16.7%
1Y Growth
20.23%

Earnings

22JulExpected
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Next
104.13
137.95
171.77
205.59
Expected EPS
173.68432862319003
Actual EPS
N/A

Financials

9.61%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
143.18BRevenue
13.77BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LONNN.MX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap195.7B
Thermo Fisher Scientific offers similar biotechnology and pharmaceutical services, including contract manufacturing and development services, competing directly with Lonza's core business.
Danaher
DHR
Mkt Cap137.82B
Danaher Corporation, through its Life Sciences segment, competes in the bioprocessing space, offering products and services that overlap with Lonza's offerings in pharmaceutical development and manufacturing.
Charles River Laboratories International
CRL
Mkt Cap9.07B
Charles River Laboratories provides a range of preclinical and clinical laboratory services for the pharmaceutical, medical device, and biotechnology industries, competing with Lonza in contract development and manufacturing organization (CDMO) services.
IQVIA
IQV
Mkt Cap29.95B
IQVIA offers extensive clinical research services, including biopharmaceutical development, which competes with Lonza's services in drug development and manufacturing.
West Pharmaceutical Services
WST
Mkt Cap19.73B
West Pharmaceutical Services specializes in designing and manufacturing containment and delivery systems for injectable drugs and healthcare products, competing with Lonza in the pharmaceutical and biotech supply chain.
Bio-Rad Laboratories
BIO
Mkt Cap8.07B
Bio-Rad Laboratories offers products and services in life science research and clinical diagnostics, competing with Lonza in the provision of specialized instruments and reagents for the pharmaceutical industry.

About

There is no Profile data available for O6Z.SI.
Show more...
CEO
ISIN
CH0013841017

Listings

MI
IT
1LONN.MI
MX
MX
LONNN.MX
F
DE
LO31.F
NEO
CA
LON.NEO

0 Comments

Share your thoughts

FAQ

What is Lonza Group stock price today?▼
The current price of LONNN.MX is M$11,842.56 MXN — it has increased by +0% in the past 24 hours. Watch Lonza Group stock price performance more closely on the chart.
What is Lonza Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Lonza Group stocks are traded under the ticker LONNN.MX.
When is the next Lonza Group earnings date?▼
Lonza Group is going to release the next earnings report on July 22, 2026.
What were Lonza Group earnings last quarter?▼
LONNN.MX earnings for the last quarter are 180.98 MXN per share, whereas the estimation was 205.59 MXN resulting in a -11.97% surprise. The estimated earnings for the next quarter are N/A MXN per share.
What is Lonza Group revenue for the last year?▼
Lonza Group revenue for the last year amounts to 143.18B MXN.
What is Lonza Group net income for the last year?▼
LONNN.MX net income for the last year is 13.77B MXN.
Does Lonza Group pay dividends?▼
Yes, LONNN.MX dividends are paid annual. The last dividend per share was 46.11 MXN. As of today, Dividend Yield (FWD)% is 0.47%.
In which sector is Lonza Group located?▼
Lonza Group operates in the Other sector.
When did Lonza Group complete a stock split?▼
Lonza Group has not had any recent stock splits.